Personalised Advice

In the meantime cannabis is extensively used by a growing group of medical users worldwide, still relying on cannabis as last resort medicine, or because it is more effective and has lesser side/effects than the prescribed one.
Unfolding the science behind the pharmacological effects of the plant-specific active compounds, cannabinoids. 

Reintroduction of cannabis as medicine needs desperately a new classification system that goes far beyond the nowadays polytypic approach in the chemotaxonomy of Cannabis including the division of Cannabis into sativa, indica, and ruderalis all subtypes of Cannabis sativa. Although important from a taxonomic point of view, from a users perspective only information about the cannabinoid content makes sense to them, irrespective of the name, smell and other phenotypic parameters

This is still in dispute, subtypes, and their blends, without information about the cannabinoid content and more importantly the concentration levels between those cannabinoids )sub/chemotypes classification is based on this). Patients rely on undefined ´´greenish plant material´´ with unknown chemotype, potency and strength, with unknown insight in the, wanted or unwanted side effects like ´´high´´, activating, energizing ´´stoney´´ , sedative´´euphoria´´, trippy-edgy effects, and many other buzz/types and in addition, appetite depressant, appetite-stimulating (exclusive attributed to the presence of THC).
We at Pharmabinoid think it is very important that our customers have access to these insights to make their product more efficient and to keep coming up with more innovative products. The right advice about the composition of your product is of the utmost importance in order to ensure that your clients have a product that suits their needs in the best way and have the right knowledge on how to use these products.

   

Feel free to contact us with any question so we can make sure you have the best product to suit you and your customer's needs